ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4,101 | 73.01599 | 1 | female | 1 | 19 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | under $11k | 41 | 101,109.75 | 64,730.2812 | null | 47 | white | 39.5 | 69 | 0.179993 | 0.092987 | 2 | 1 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 18 | 54 | 12 | 116 | 10 | 38.5 | 182.84375 | 2.199707 | 7.5 | 4.199219 | 133 | 7.339844 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,102 | 71.573 | 1 | male | 0 | 17 | 807 | COPD | COPD/CHF/Cirrhosis | 2 | null | null | 9 | 33,095.094 | 20,809.25 | null | 22 | black | 21.5 | 38 | 0.790894 | 0.664917 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 17 | 80 | 7.299805 | 164 | 25 | 36.19531 | 352.8125 | null | 0.599976 | 1 | 137 | 7.599609 | null | null | null | null | null | null | 3.430176 |
4,103 | 61.81799 | 1 | male | 0 | 7 | 762 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | $11-$25k | 0 | 16,462.984 | 11,815.6094 | null | 14 | white | 25.097656 | 35 | 0.810913 | 0.692993 | 1 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 7 | 123 | 16.796875 | 134 | 28 | 36.29688 | 195.90625 | null | 0.099991 | 1.099854 | 134 | 7.509766 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,104 | 71.63898 | 0 | female | 0 | 20 | 1,422 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | $11-$25k | 0 | 46,942.281 | 31,829.9219 | null | 27.666656 | white | 21.199219 | 33 | 0.823975 | 0.763916 | 1 | 0 | 0 | no | null | null | no dnr | 20 | 61 | 8.199219 | 104 | 12 | 36.19531 | 236.65625 | null | 0.599976 | 2.299805 | 142 | 7.469727 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
4,105 | 80.78296 | 1 | female | 1 | 8 | 8 | Coma | Coma | 0 | null | null | 44 | 16,429.391 | 10,578.7656 | null | 22.5 | black | 20.699219 | 31 | 0.429993 | 0.355957 | 1 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 8 | 119 | 21.597656 | 104 | 30 | 37.89844 | 316.625 | 4.299805 | null | 0.699951 | 142 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,106 | 64.92499 | 1 | female | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | $11-$25k | 0 | 14,077.844 | 9,115.2031 | null | 37 | black | 30.699219 | 57 | 0.690918 | 0.598999 | 1 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 4 | 60 | 16.097656 | 114 | 27 | 38.5 | 292 | null | 2.899902 | 8.599609 | 128 | 7.399414 | null | null | null | null | null | <2 mo. follow-up | 2.262695 |
4,107 | 65.19897 | 1 | female | 0 | 26 | 244 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | null | 0 | 78,598.625 | 50,603.0312 | null | 23.25 | white | 30.199219 | 47 | 0.615967 | 0.510986 | 13 | 0 | 0 | no | null | null | no dnr | 26 | 55 | 27.699219 | 124 | 24 | 37.89844 | 140 | 1.899902 | 1.099854 | 0.699951 | 146 | 7.419922 | null | null | null | 4 | 0 | no(M2 and SIP pres) | 0 |
4,108 | 69.99896 | 1 | female | 1 | 24 | 24 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | under $11k | 26 | 110,167.938 | 70,867 | null | 41 | white | 35.695313 | 52 | 0.295959 | 0.184998 | 14 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 22 | 65 | 10.798828 | 136 | 28 | 39.09375 | 60 | 1.5 | 1 | 0.5 | 133 | 7.459961 | null | null | null | 0 | 1 | <2 mo. follow-up | 1 |
4,109 | 72.849 | 1 | male | 0 | 27 | 105 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 73,245.688 | 49,878.3125 | null | 23.5 | black | 27 | 50 | 0.579956 | 0.386963 | 1 | 0 | 1 | metastatic | 0.4 | 0.4 | no dnr | 27 | 79 | 9.5 | 156 | 40 | 37.59375 | 217.84375 | 2.5 | 0.299988 | 1 | 139 | 7.439453 | null | null | null | null | 5 | adl>=4 (>=5 if sur) | 5 |
4,110 | 60.41898 | 1 | male | 1 | 38 | 38 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 18 | >$50k | 0 | 316,291 | 198,929.125 | null | 35 | white | 21.699219 | 17 | 0.784912 | 0.714966 | 80 | 0 | 0 | no | null | null | dnr after sadm | 37 | 89 | 18 | 100 | 7 | 38.59375 | 276.625 | null | 0.099991 | 1.599854 | 129 | 7.449219 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
4,111 | 43.93198 | 1 | male | 0 | 9 | 258 | Lung Cancer | Cancer | 1 | 10 | null | 0 | null | null | null | 10.5 | white | 13.298828 | 21 | 0.81189 | 0.596924 | 1 | 0 | 0 | metastatic | null | null | no dnr | 9 | 110 | 2.5 | 104 | 32 | 37.5 | null | 3.899902 | 0.099991 | 0.699951 | 142 | null | null | null | null | 5 | 5 | SIP>=30 | 5 |
4,112 | 81.81799 | 1 | female | 0 | 7 | 17 | Colon Cancer | Cancer | 1 | 18 | null | 0 | 5,206.25 | 3,978.8965 | null | 8 | white | 26.398438 | 22 | 0.594971 | 0.27594 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | no dnr | 7 | 115 | 9.599609 | 74 | 22 | 35.79688 | null | 2.599609 | 0.699951 | 0.899902 | 144 | null | null | null | null | null | 6 | <2 mo. follow-up | 6 |
4,113 | 61.133 | 1 | male | 0 | 12 | 213 | Lung Cancer | Cancer | 1 | 16 | $25-$50k | 0 | 14,348.945 | 9,699.9844 | null | 14.5 | white | 25.398438 | 18 | 0.517944 | 0.195984 | 1 | 0 | 0 | metastatic | null | null | no dnr | 12 | 107 | 9.199219 | 64 | 10 | 36.5 | 371.375 | 2.799805 | 1.399902 | 1 | 136 | 7.399414 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,114 | 57.58197 | 1 | female | 0 | 22 | 84 | Lung Cancer | Cancer | 1 | 9 | null | 0 | 19,568.297 | 14,059.5469 | null | 7.666664 | white | 21.199219 | 19 | 0.636963 | 0.327942 | 1 | 0 | 0 | metastatic | 0.6 | 0.2 | no dnr | 22 | 78 | 8.298828 | 116 | 20 | 36.59375 | null | null | 0.399963 | 0.599976 | 133 | null | null | null | null | 6 | null | no(M2 and SIP pres) | 4.527397 |
4,115 | 76.98798 | 1 | male | 0 | 37 | 92 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 26 | 103,783.375 | 69,377.75 | null | 28.25 | white | 31.597656 | 52 | 0.332947 | 0.217987 | 4 | 0 | 0 | yes | 0.5 | 0.5 | no dnr | 37 | 110 | 18.699219 | 140 | 40 | 38.39844 | 144.875 | 2.5 | 1 | 1.899902 | 150 | 7.429688 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
4,116 | 74.89697 | 1 | female | 0 | 9 | 167 | COPD | COPD/CHF/Cirrhosis | 4 | 9 | $11-$25k | 0 | 12,089.344 | 7,884.4219 | null | 10.5 | white | 22.398438 | 32 | 0.779907 | 0.647949 | 1 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 9 | 105 | 13.798828 | 120 | 28 | 36.29688 | 311.0625 | null | null | 1.099854 | 138 | 7.40918 | null | null | null | 1 | 1 | adl>=4 (>=5 if sur) | 1 |
4,117 | 73.20197 | 0 | female | 0 | 19 | 1,415 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 9 | 38,421.125 | 26,814.0312 | null | 18.333328 | white | 25 | 51 | 0.73291 | 0.650879 | 1 | 1 | 0 | no | 0.1 | 0.001 | no dnr | 19 | 141 | 7.699219 | 50 | 8 | 36.5 | 248 | 1.399902 | 1.099854 | 2.799805 | 158 | 7.429688 | null | null | null | null | 0 | null | 0 |
4,118 | 28.09299 | 1 | male | 0 | 5 | 180 | Colon Cancer | Cancer | 1 | 8 | null | 0 | 7,952.297 | 4,544.7227 | null | 11 | white | 17.398438 | 8 | 0.870972 | 0.708984 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 5 | 77 | 9.298828 | 80 | 20 | 36.59375 | null | 3.199707 | null | 0.899902 | 139 | null | null | null | null | 0 | 1 | adl>=4 (>=5 if sur) | 1 |
4,119 | 60.15298 | 1 | male | 0 | 14 | 205 | Lung Cancer | Cancer | 1 | 14 | $11-$25k | 0 | 17,149.938 | 11,558.3047 | null | 8.333328 | white | 10.798828 | 9 | 0.81897 | 0.609985 | 1 | 0 | 0 | metastatic | 0.5 | 0.4 | no dnr | 14 | 83 | 6.599609 | 86 | 20 | 38.39844 | 224.96875 | 3.699707 | 0.399963 | 0.699951 | 139 | 7.419922 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,120 | 41.13898 | 1 | male | 0 | 5 | 89 | Lung Cancer | Cancer | 1 | 8 | under $11k | 0 | 4,330.859 | 2,927.4707 | null | 4 | white | 11.398438 | 5 | 0.840942 | 0.649902 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 5 | 87 | null | 80 | 24 | 36.69531 | null | 3.799805 | 0.199982 | 0.599976 | 141 | null | null | null | null | 0 | null | null | 0.4948 |
4,121 | 64.71497 | 1 | male | 0 | 6 | 1,029 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 0 | 4,430.047 | 3,109.2207 | null | 7 | white | 17.097656 | 20 | 0.806885 | 0.688965 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 70 | 10.398438 | 70 | 20 | 36.39844 | null | 2.599609 | 2.199707 | 0.899902 | 135 | null | null | null | null | 4 | 3 | no(M2 and SIP pres) | 3 |
4,122 | 30.33499 | 1 | female | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | >$50k | 61 | null | null | null | 41.5 | white | 32.09375 | 58 | 0.546997 | 0.43396 | 4 | 0 | 0 | no | null | null | dnr after sadm | 9 | 140 | 6.5 | 156 | 26 | 38.59375 | 82.21875 | null | 2.699707 | 0.799927 | 145 | 7.269531 | null | null | null | null | null | <2 mo. follow-up | 2.725098 |
4,123 | 53.22098 | 1 | female | 1 | 109 | 109 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | $25-$50k | 0 | 530,330 | 338,627.25 | null | 47 | white | 23.199219 | 44 | 0.802979 | 0.737915 | 14 | 1 | 0 | no | 0.75 | 0.75 | dnr after sadm | 104 | 75 | 27.699219 | 96 | 12 | 37.89844 | 272 | null | 2.5 | 2.199707 | 134 | 7.439453 | null | null | null | null | 0 | null | 0 |
4,124 | 78.10498 | 1 | female | 1 | 30 | 30 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 2 | under $11k | 0 | 73,564.562 | 49,620.125 | null | 15.25 | white | 27.296875 | 45 | 0.615967 | 0.510986 | 11 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 30 | 63 | 18.5 | 120 | 28 | 37.39844 | 293.3125 | null | null | 2.5 | 135 | 7.379883 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
4,125 | 69.04297 | 1 | female | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 7 | null | 26 | 86,513.75 | 56,714.1562 | null | 48.666657 | white | 29.199219 | 63 | 0.598999 | 0.491943 | 1 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 5 | 62 | 13.798828 | 66 | 39 | 36.59375 | 147.5 | 2.5 | 2.5 | 2.099609 | 145 | 7.169922 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
4,126 | 26.519 | 0 | female | 0 | 17 | 1,410 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 32,705.891 | 21,617.4688 | null | 16.333328 | black | 34.09375 | 84 | 0.778931 | 0.707886 | 2 | 1 | 0 | no | null | null | no dnr | 17 | 145 | 49.695313 | 166 | 56 | 38.89844 | 132.625 | 1.5 | 2.799805 | 1.099854 | 132 | 7.429688 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
4,127 | 64.52295 | 1 | female | 0 | 15 | 1,409 | COPD | COPD/CHF/Cirrhosis | 2 | 18 | >$50k | 0 | 14,548.125 | 9,736.9297 | null | 13.333328 | white | 11.798828 | 17 | 0.928955 | 0.878906 | 1 | 0 | 0 | no | 0.99 | 0.95 | no dnr | 15 | 73 | 3.899902 | 105 | 20 | 36.89844 | 260.8125 | 4.399414 | 0.299988 | 0.699951 | 141 | 7.389648 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,128 | 71.79999 | 0 | male | 0 | 8 | 1,409 | COPD | COPD/CHF/Cirrhosis | 1 | 6 | null | 0 | 6,795.148 | 4,689 | null | 8.5 | white | 25.199219 | 32 | 0.755981 | 0.613892 | 1 | 0 | 0 | no | 0.75 | 0.6 | no dnr | 8 | 100 | 9.398438 | 110 | 22 | 36.29688 | 156 | 3.199707 | 0.099991 | 0.699951 | 141 | 7.359375 | null | null | null | 1 | 0 | null | 0 |
4,129 | 64.10095 | 1 | male | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 15 | $11-$25k | 0 | 45,839.344 | 27,262.6094 | null | 39.5 | white | 30.5 | 40 | 0.646973 | 0.546997 | 5 | 1 | 0 | no | 0.1 | 0.001 | dnr after sadm | 8 | 65 | 11.099609 | 64 | 24 | 35.29688 | 352 | null | null | 5.299805 | 128 | 7.339844 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,130 | 74.36798 | 0 | female | 0 | 12 | 1,409 | MOSF w/Malig | ARF/MOSF | 1 | null | under $11k | 0 | 15,472.344 | 10,627.0859 | null | 19.5 | black | 21.699219 | 39 | 0.730957 | 0.647949 | 1 | 0 | 0 | yes | 0.95 | 0.9 | no dnr | 12 | 57 | 11.099609 | 70 | 28 | 36.69531 | 412 | 2.799805 | 0.899902 | 1.699951 | 143 | 7.339844 | null | null | null | null | null | no(M2 and SIP pres) | 2.503906 |
4,131 | 81.10297 | 1 | male | 0 | 21 | 615 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 20,806.703 | 16,225.6094 | null | 13.333328 | white | 16.898438 | 39 | 0.708984 | 0.54895 | 1 | 0 | 0 | no | null | null | no dnr | 21 | 100 | 3.799805 | 72 | 18 | 36.59375 | 228.5625 | 2.899902 | 2.099609 | 1.399902 | 148 | 7.449219 | null | null | null | null | null | null | 2.790527 |
4,132 | 56.64099 | 1 | male | 0 | 18 | 60 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 21,573.094 | 14,371.5078 | null | 10 | white | 28.699219 | 17 | 0.439941 | 0.130981 | 1 | 0 | 0 | metastatic | 0.5 | 0.25 | dnr after sadm | 14 | 84 | 18 | 126 | 22 | 37 | 319 | 2.899902 | null | 0.699951 | 141 | 7.479492 | null | null | null | 0 | 0 | null | 0 |
4,133 | 47.21997 | 1 | male | 0 | 7 | 400 | Colon Cancer | Cancer | 1 | 16 | >$50k | 0 | 7,890.449 | 5,285.582 | null | 11 | white | 8.798828 | 7 | 0.917969 | 0.809937 | 1 | 0 | 0 | metastatic | 0.9 | 0.6 | no dnr | 7 | 80 | 4.299805 | 100 | 22 | 38.59375 | null | 4 | 0.299988 | 0.899902 | 142 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
4,134 | 66.42297 | 1 | female | 0 | 11 | 109 | Colon Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 6,924.148 | 5,220.8633 | null | 8.5 | white | 18.199219 | 13 | 0.797974 | 0.570923 | 1 | 0 | 0 | metastatic | null | null | no dnr | 11 | 87 | 6.299805 | 100 | 28 | 37.79688 | 447.5625 | null | null | 0.599976 | 139 | 7.569336 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
4,135 | 61.07599 | 1 | female | 0 | 5 | 134 | Colon Cancer | Cancer | 1 | 12 | under $11k | 0 | 5,752.047 | 3,460.1836 | null | 10 | white | 12.199219 | 11 | 0.876953 | 0.7229 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 5 | 113 | 5.5 | 70 | 24 | 35.69531 | null | 3.899902 | 0.199982 | 0.699951 | 141 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,136 | 47.35898 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | null | 0 | 31,451.266 | 18,780.1094 | null | 49 | black | 27.097656 | 51 | 0.822998 | 0.762939 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 5 | 55 | 13.099609 | 124 | 30 | 40.69531 | 300 | 1.299805 | 0.099991 | 0.799927 | 136 | 7.439453 | null | null | null | null | null | <2 mo. follow-up | 1.888184 |
4,137 | 61.65598 | 1 | female | 1 | 10 | 10 | MOSF w/Malig | ARF/MOSF | 1 | 13 | >$50k | 44 | 68,828.75 | 42,445.4375 | null | 47.5 | white | 41.398438 | 87 | 0.028999 | 0.007 | 8 | 0 | 0 | yes | null | null | dnr after sadm | 9 | 110 | 0.199982 | 120 | 42 | 38.5 | 248 | null | 8.798828 | 2.899902 | 140 | 7.359375 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,138 | 64.60797 | 1 | female | 0 | 5 | 93 | Colon Cancer | Cancer | 1 | 8 | null | 0 | 5,229.797 | 3,796.2519 | null | 7 | black | 19 | 21 | 0.789917 | 0.556885 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 81 | 10.599609 | 64 | 28 | 36.39844 | 352.375 | null | 1.399902 | 1.399902 | 139 | 7.5 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
4,139 | 80.37 | 1 | male | 1 | 87 | 87 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | under $11k | 0 | null | null | null | 39.25 | white | 43.898438 | 96 | 0.233978 | 0.132996 | 1 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 15 | 49 | 29.699219 | 80 | 36 | 34 | 146.65625 | 1.299805 | 2.699707 | 2.299805 | 153 | 7.469727 | null | null | null | null | null | null | 2.986816 |
4,140 | 70.74298 | 0 | female | 0 | 21 | 1,397 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | null | 26 | 93,786.312 | 58,329.4062 | null | 27 | hispanic | 30.398438 | 45 | 0.469971 | 0.350952 | 8 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 21 | 62 | 12.798828 | 110 | 8 | 36.19531 | 383.3125 | 2.899902 | 5.299805 | 2.299805 | 147 | 7.419922 | null | null | null | null | 7 | null | 7 |
4,141 | 45.84497 | 0 | male | 0 | 10 | 1,396 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | $25-$50k | 0 | 17,144.141 | 12,614.4609 | null | 18 | black | 18 | 22 | 0.912964 | 0.881958 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 10 | 101 | 18.699219 | 104 | 31 | 37.89844 | 246.65625 | 2.699707 | 0.199982 | 1 | 139 | 7.399414 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,142 | 52.22998 | 1 | female | 1 | 4 | 4 | Lung Cancer | Cancer | 1 | 12 | under $11k | 100 | 6,356.336 | 4,161.4805 | null | 28 | black | 74.09375 | 72 | 0 | 0 | 1 | 0 | 0 | metastatic | 0.1 | 0.001 | no dnr | 4 | 0 | 18.5 | 0 | 0 | 38.69531 | 223.78125 | null | null | 0.699951 | 126 | 7.439453 | null | null | null | null | null | <2 mo. follow-up | 2.356934 |
4,143 | 47.16998 | 0 | male | 0 | 90 | 1,396 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 163,735.875 | 111,310.188 | null | 20.5 | black | 20.097656 | 18 | 0.894897 | 0.85791 | 1 | 0 | 0 | no | 0.65 | 0.65 | no dnr | 90 | 137 | 9.699219 | 136 | 12 | 37.59375 | 360 | null | 0.899902 | 1.199951 | 134 | 7.439453 | null | null | null | null | null | null | 1.798096 |
4,144 | 53.18799 | 0 | male | 0 | 7 | 1,396 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 15,708.242 | 11,773.0078 | null | 7.5 | white | 15.699219 | 17 | 0.921997 | 0.86792 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 7 | 82 | 5.799805 | 80 | 20 | 36.19531 | 432 | null | 0.599976 | 1.5 | 141 | 7.459961 | null | null | null | 2 | 1 | no(M2 and SIP pres) | 1 |
4,145 | 78.09198 | 1 | female | 0 | 6 | 303 | CHF | COPD/CHF/Cirrhosis | 2 | 7 | under $11k | 0 | 11,205.695 | 7,529.1602 | null | 29 | black | 25 | 42 | 0.74292 | 0.594971 | 1 | 1 | 0 | no | 0.7 | 0.7 | no dnr | 6 | 73 | 11.298828 | 130 | 25 | 36.89844 | 372 | null | null | 1.899902 | 141 | 7.459961 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
4,146 | 70.47797 | 1 | male | 0 | 6 | 51 | Colon Cancer | Cancer | 1 | null | null | 0 | 6,633.75 | 4,108.207 | null | 9 | black | 24.898438 | 29 | 0.664917 | 0.363953 | 1 | 1 | 0 | metastatic | 0.7 | 0.1 | no dnr | 6 | 113 | 10.699219 | 80 | 28 | 36.39844 | null | 2.899902 | 2.399902 | 0.899902 | 138 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
4,147 | 61.89999 | 1 | male | 1 | 106 | 106 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | null | null | null | 23 | white | 38.296875 | 52 | 0.387939 | 0.269958 | 41 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 9 | 81 | 14.199219 | 124 | 33 | 35.09375 | 193.3125 | 3.399902 | 1.5 | 4.399414 | 130 | 7.479492 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
4,148 | 57.47299 | 1 | female | 0 | 18 | 222 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 17,594.547 | 11,910.8281 | null | 7.666664 | white | 13.298828 | 15 | 0.871948 | 0.710938 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 18 | 74 | 10.5 | 84 | 20 | 37.59375 | null | null | 0.299988 | 0.899902 | 140 | null | null | null | null | 0 | 3 | no(M2 and SIP pres) | 3 |
4,149 | 39.93198 | 0 | male | 0 | 45 | 1,393 | Coma | Coma | 1 | 8 | under $11k | 44 | 93,780.188 | 60,261.5938 | null | 35.25 | white | 17.699219 | 17 | 0.812988 | 0.775879 | 1 | 0 | 0 | no | 0.3 | 0.2 | dnr after sadm | 10 | 72 | 16.296875 | 70 | 30 | 36.5 | 242.84375 | null | 0.199982 | 0.799927 | 144 | 7.459961 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
4,150 | 48.077 | 0 | female | 0 | 10 | 1,392 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 9,770.945 | 6,952.6992 | null | 8.5 | white | 16.597656 | 27 | 0.882935 | 0.804932 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 10 | 77 | 6 | 74 | 20 | 37.79688 | null | 2.299805 | 4.5 | 0.799927 | 136 | null | null | null | null | 7 | 7 | no(M2 and SIP pres) | 7 |
4,151 | 60.59399 | 1 | female | 1 | 7 | 7 | MOSF w/Malig | ARF/MOSF | 0 | 3 | null | 100 | 60,863.469 | 40,220.8438 | null | 22.5 | white | 48 | 68 | 0 | 0 | 26 | 0 | 0 | yes | 0 | 0 | dnr after sadm | 2 | 43 | 0.899902 | 114 | 12 | 40 | 298 | null | 5 | 1.699951 | 129 | 7.40918 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
4,152 | 56.35898 | 0 | female | 0 | 16 | 1,391 | MOSF w/Malig | ARF/MOSF | 1 | 14 | $25-$50k | 0 | 28,776.484 | 19,103.0938 | null | 16.666656 | white | 31 | 73 | 0.43396 | 0.313965 | 2 | 0 | 0 | metastatic | 0.6 | 0.5 | no dnr | 16 | 60 | 6.699219 | 122 | 40 | 38.5 | 248 | 2.399902 | 2.599609 | 2.199707 | 127 | 7.399414 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,153 | 84.69299 | 1 | male | 1 | 44 | 44 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | null | 44 | 94,629 | 66,053.125 | null | 20 | black | 28.097656 | 56 | 0.311951 | 0.198975 | 23 | 1 | 0 | no | 0.5 | 0.125 | dnr after sadm | 2 | 111 | 12.398438 | 60 | 3 | 36.5 | 217.125 | 2.899902 | 0.799927 | 3.099609 | 142 | 7.40918 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
4,154 | 67.07196 | 1 | male | 0 | 4 | 94 | Lung Cancer | Cancer | 1 | 16 | $25-$50k | 0 | 1,635.75 | 1,285.1836 | null | 7 | white | 14 | 8 | 0.758911 | 0.504883 | 1 | 0 | 0 | metastatic | 0.8 | 0.6 | no dnr | 4 | 90 | 6.899414 | 72 | 22 | 36.69531 | null | null | 1.299805 | 1 | 141 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,155 | 55.75897 | 0 | female | 0 | 12 | 1,390 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 54,305.781 | 32,730.2031 | null | 27.5 | white | 21.097656 | 21 | 0.85791 | 0.80896 | 2 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 12 | 63 | 11.599609 | 114 | 6 | 38.09375 | 226.65625 | null | 1.699951 | 0.699951 | 144 | 7.359375 | null | null | null | 0 | 0 | SIP>=30 | 0 |
4,156 | 67.77295 | 1 | female | 1 | 37 | 37 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 11 | under $11k | 44 | 60,532.938 | 38,475 | null | 21 | white | 26.296875 | 36 | 0.600952 | 0.492981 | 1 | 1 | 0 | no | null | null | no dnr | 37 | 94 | 22 | 130 | 28 | 38.5 | 186.65625 | null | 0.799927 | 1.599854 | 135 | 7.329102 | null | null | null | 5 | 6 | <2 mo. follow-up | 6 |
4,157 | 69.95996 | 1 | female | 0 | 3 | 77 | CHF | COPD/CHF/Cirrhosis | 4 | 3 | under $11k | 0 | 1,672.449 | 1,343.5801 | null | 7 | black | 16.796875 | 25 | 0.878906 | 0.79895 | 1 | 1 | 0 | no | 0.9 | 0.5 | no dnr | 3 | 80 | 4.299805 | 64 | 28 | 36.5 | 366.625 | null | null | 1.299805 | 140 | 7.40918 | null | null | null | null | null | no(M2 and SIP pres) | 2.993164 |
4,158 | 65.39398 | 1 | male | 1 | 3 | 3 | Coma | Coma | 1 | 7 | under $11k | 100 | 14,855.242 | 9,849.8047 | null | 41 | black | 75.390625 | 80 | 0 | 0 | 1 | 0 | 0 | no | 0.05 | 0.000125 | no dnr | 3 | 0 | 9.398438 | 0 | 14 | 35.09375 | 187.5 | 1.799805 | null | 4.399414 | 143 | 7.329102 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,159 | 78.92694 | 0 | male | 0 | 35 | 1,387 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 37 | 59,747.969 | 40,751.8125 | null | 22.25 | black | 29.199219 | 62 | 0.434998 | 0.315979 | 3 | 0 | 0 | no | null | null | dnr after sadm | 6 | 65 | 15 | 64 | 26 | 36.69531 | 137.5 | 2.199707 | 0.299988 | 10.898438 | 129 | 7.399414 | null | null | null | null | null | null | 3.630371 |
4,160 | 76.65399 | 1 | female | 0 | 7 | 33 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 4,969.898 | 3,531.9766 | null | 10.5 | white | 21.097656 | 22 | 0.809937 | 0.691895 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 7 | 71 | 11.699219 | 56 | 16 | 35.09375 | 400 | null | null | 1.199951 | 137 | 7.5 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,161 | 57.05698 | 1 | male | 1 | 6 | 6 | Lung Cancer | Cancer | 1 | null | null | 0 | 8,189.148 | 5,071.8945 | null | 18 | white | 27.898438 | 20 | 0.461975 | 0.14798 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 2 | 83 | 6.099609 | 114 | 28 | 36.39844 | 356.625 | 2.799805 | 0.299988 | 0.799927 | 139 | 7.299805 | null | null | null | null | null | <2 mo. follow-up | 2.410645 |
4,162 | 48.51999 | 0 | male | 0 | 81 | 1,385 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 322,828.75 | 205,589.25 | null | 48 | white | 34.398438 | 57 | 0.610962 | 0.504883 | 13 | 0 | 0 | no | null | null | no dnr | 81 | 54 | 15 | 124 | 28 | 39.39844 | 190 | 2.299805 | 1 | 2.399902 | 150 | 7.419922 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
4,163 | 61.71899 | 1 | female | 0 | 11 | 577 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 31,584.484 | 20,443.0781 | null | 19.5 | white | 23.699219 | 14 | 0.767944 | 0.69397 | 11 | 0 | 0 | no | null | null | no dnr | 11 | 101 | 11 | 124 | 23 | 36.29688 | 316.3125 | 2.899902 | 0.5 | 0.5 | 141 | 7.389648 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,164 | 55.36798 | 1 | female | 0 | 28 | 108 | CHF | COPD/CHF/Cirrhosis | 3 | 13 | under $11k | 0 | 75,277.938 | 46,333.0625 | null | 29.5 | white | 19.796875 | 19 | 0.873901 | 0.790894 | 3 | 1 | 0 | no | 0.85 | 0.8 | no dnr | 28 | 82 | 5.899414 | 110 | 26 | 39 | null | null | null | 0.699951 | 137 | null | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
4,165 | 50.17697 | 0 | female | 0 | 30 | 1,382 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | $11-$25k | 41 | 94,015.438 | 60,084.4062 | null | 26 | black | 19.796875 | 20 | 0.776978 | 0.704956 | 5 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 30 | 130 | 20.199219 | 114 | 24 | 38.39844 | 250 | 3.899902 | null | 0.799927 | 137 | 7.419922 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
4,166 | 34.15698 | 0 | female | 0 | 13 | 1,382 | CHF | COPD/CHF/Cirrhosis | 0 | 18 | >$50k | 0 | 31,092.484 | 21,191.4688 | null | 31 | white | 22.699219 | 20 | 0.910889 | 0.849976 | 1 | 0 | 0 | no | null | null | no dnr | 13 | 112 | 8.298828 | 110 | 26 | 36.79688 | 266.625 | 2.899902 | 0.899902 | 1 | 136 | 7.469727 | null | null | null | 1 | 1 | null | 1 |
4,167 | 50.62299 | 0 | female | 0 | 23 | 1,382 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | $11-$25k | 0 | 52,901.719 | 36,472.8125 | null | 27 | white | 18.398438 | 25 | 0.901978 | 0.866943 | 1 | 0 | 0 | no | null | null | no dnr | 23 | 114 | 7.199219 | 104 | 30 | 38.5 | 256.625 | 2 | 1.199951 | 0.599976 | 140 | 7.5 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,168 | 69.81195 | 1 | male | 1 | 7 | 7 | MOSF w/Malig | ARF/MOSF | 1 | 0 | under $11k | 0 | 58,640.125 | 36,645.7812 | null | 41.5 | white | 34.695313 | 64 | 0.297974 | 0.186981 | 15 | 0 | 0 | yes | null | null | dnr after sadm | 6 | 109 | 0.5 | 174 | 29 | 40.19531 | 166 | null | 0.599976 | 0.799927 | 138 | 7.469727 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,169 | 85.53894 | 0 | male | 0 | 21 | 1,379 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 9 | 28,541.031 | 19,546.8594 | null | 12.333328 | black | 23.796875 | 24 | 0.56189 | 0.449951 | 7 | 0 | 0 | yes | null | null | no dnr | 21 | 93 | 11 | 80 | 26 | 36 | 146.9375 | null | 0.199982 | 1.299805 | 146 | 7.399414 | null | null | null | 4 | 2 | no(M2 and SIP pres) | 2 |
4,170 | 53.18799 | 1 | male | 0 | 101 | 285 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 11 | null | 0 | 284,256.75 | 193,046.75 | null | 39 | white | 40.296875 | 43 | 0.526978 | 0.411987 | 1 | 0 | 0 | no | null | null | no dnr | 101 | 39 | 16 | 124 | 10 | 36.5 | 165.6875 | 2.699707 | null | 1.399902 | 148 | 7.449219 | null | null | null | null | 2 | adl>=4 (>=5 if sur) | 2 |
4,171 | 43.39499 | 0 | female | 0 | 17 | 1,379 | MOSF w/Malig | ARF/MOSF | 1 | 12 | $25-$50k | 9 | 68,084.312 | 44,917.2812 | null | 23.666656 | white | 28.398438 | 43 | 0.593994 | 0.485962 | 1 | 0 | 0 | yes | null | null | no dnr | 17 | 107 | 3 | 130 | 46 | 36 | 304.75 | 2.099609 | null | 1 | 140 | 7.449219 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
4,172 | 65.90594 | 1 | male | 1 | 5 | 5 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 3,840.35 | 2,740.5918 | null | 13 | white | 36.195313 | 70 | 0.352966 | 0.162994 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 73 | 8.099609 | 76 | 22 | 35.29688 | 457.125 | 1.799805 | 26.296875 | 3.5 | 130 | 7.419922 | null | null | null | 5 | null | <2 mo. follow-up | 3.855299 |
4,173 | 54.42798 | 0 | male | 0 | 46 | 1,378 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 26 | 149,515 | 97,945.25 | null | 24.5 | black | 26.097656 | 44 | 0.655884 | 0.556885 | 18 | 1 | 0 | no | 0.9 | 0.8 | no dnr | 46 | 102 | 16.296875 | 104 | 28 | 38.09375 | 150 | 1.699951 | null | 1.699951 | 146 | 7.389648 | null | null | null | null | 7 | no(M2 and SIP pres) | 7 |
4,174 | 54.754 | 0 | female | 0 | 19 | 1,378 | CHF | COPD/CHF/Cirrhosis | 3 | 10 | $25-$50k | 0 | 45,468.906 | 28,772.2188 | null | 25 | black | 18.597656 | 18 | 0.898926 | 0.830933 | 1 | 0 | 0 | no | null | null | dnr after sadm | 5 | 83 | 4.599609 | 74 | 36 | 36.09375 | 290 | null | null | 0.799927 | 134 | 7.479492 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
4,175 | 79.55396 | 1 | female | 1 | 12 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 57,881.625 | 38,559.0312 | null | 28.5 | white | 31.796875 | 50 | 0.505981 | 0.388977 | 7 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 6 | 115 | 10.898438 | 180 | 36 | 36.79688 | 126.65625 | null | null | 1.699951 | 138 | 7.439453 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,176 | 52.586 | 1 | male | 1 | 39 | 39 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 9 | 156,079.125 | 99,411.4375 | null | 17.75 | white | 30.199219 | 56 | 0.655884 | 0.556885 | 10 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 39 | 60 | 28.5 | 156 | 32 | 36 | 476.1875 | 2.5 | 1.799805 | 2.199707 | 146 | 7.439453 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,177 | 89.35199 | 0 | female | 0 | 18 | 1,377 | COPD | COPD/CHF/Cirrhosis | 3 | 14 | $25-$50k | 0 | 26,882.234 | 17,633.8281 | null | 20.666656 | white | 27.199219 | 37 | 0.544922 | 0.346985 | 1 | 0 | 0 | no | null | null | no dnr | 18 | 103 | 11.398438 | 124 | 28 | 36.19531 | 157.125 | null | 0.799927 | 1.299805 | 140 | 7.439453 | null | null | null | null | 4 | no(M2 and SIP pres) | 4 |
4,178 | 62.37598 | 1 | male | 1 | 28 | 28 | MOSF w/Malig | ARF/MOSF | 1 | 19 | >$50k | 0 | 88,716.75 | 55,218.75 | null | 23.5 | white | 29 | 49 | 0.492981 | 0.375 | 10 | 0 | 0 | yes | null | null | dnr after sadm | 22 | 61 | 0.099991 | 126 | 30 | 38.79688 | 256 | null | 0.799927 | 0.899902 | 138 | 7.479492 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
4,179 | 72.45197 | 1 | male | 0 | 7 | 52 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 14,996.648 | 8,643.25 | null | 14.5 | white | 40.59375 | 40 | 0.080994 | 0.002 | 1 | 0 | 0 | metastatic | null | null | no dnr | 7 | 57 | 17.199219 | 146 | 24 | 35.69531 | null | 2.099609 | 0.199982 | 0.899902 | 137 | null | null | null | null | null | 2 | <2 mo. follow-up | 2 |
4,180 | 44.70599 | 0 | male | 0 | 14 | 1,375 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | >$50k | 0 | 54,420.094 | 32,991.3438 | null | 32 | white | 26 | 34 | 0.831909 | 0.775879 | 2 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 14 | 67 | 12.5 | 74 | 5 | 36.59375 | 146.65625 | null | null | 1.399902 | 136 | 7.429688 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
4,181 | 84.95294 | 1 | female | 1 | 5 | 5 | MOSF w/Malig | ARF/MOSF | 2 | 16 | $11-$25k | 44 | 43,507.656 | 27,881.4688 | null | 31 | white | 49.296875 | 96 | 0 | 0 | 17 | 0 | 0 | yes | null | null | dnr after sadm | 4 | 51 | 0.199982 | 140 | 27 | 39.09375 | 128.3125 | 2.599609 | 3.299805 | 3.299805 | 141 | 7.5 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,182 | 40.82999 | 1 | male | 0 | 12 | 73 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | null | null | 9 | 10,073.695 | 7,346.5 | null | 9 | black | 27.199219 | 40 | 0.763916 | 0.625 | 1 | 0 | 0 | no | null | null | no dnr | 12 | 83 | 13 | 108 | 20 | 36.29688 | 323.75 | 1.099854 | 13.5 | 1.199951 | 146 | 7.469727 | null | null | null | null | null | null | 3.671387 |
4,183 | 72.97998 | 0 | male | 0 | 19 | 1,365 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 37,242.969 | 24,578.5469 | null | 22 | black | 33.695313 | 37 | 0.575928 | 0.465942 | 1 | 0 | 0 | no | 0.9 | 0.88 | no dnr | 19 | 87 | 10.699219 | 146 | 33 | 37 | 205.6875 | 3.099609 | 0.5 | 1.699951 | 121 | 7.389648 | null | null | null | null | null | null | 2.907715 |
4,184 | 63.74799 | 1 | female | 1 | 32 | 32 | MOSF w/Malig | ARF/MOSF | 1 | 12 | null | 0 | null | null | null | 21.25 | white | 33.5 | 63 | 0.278992 | 0.169983 | 8 | 0 | 0 | metastatic | 0.95 | 0.85 | dnr after sadm | 30 | 130 | 10.898438 | 136 | 32 | 39.19531 | 193.3125 | 2.199707 | 8.599609 | 1.899902 | 137 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,185 | 57.35498 | 0 | male | 0 | 39 | 1,364 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 10 | under $11k | 37 | 104,662.625 | 67,909.6875 | null | 30.5 | black | 32.195313 | 64 | 0.542969 | 0.428955 | 1 | 0 | 0 | no | null | null | no dnr | 39 | 63 | 10.798828 | 126 | 24 | 38.89844 | 224 | 1.699951 | 16.097656 | 1.899902 | 149 | 7.389648 | null | null | null | null | null | SIP>=30 | 2.34375 |
4,186 | 56.40198 | 1 | male | 1 | 15 | 15 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 14 | >$50k | 0 | 37,778.875 | 24,318.8906 | null | 27 | white | 20.699219 | 46 | 0.799927 | 0.677979 | 1 | 0 | 0 | no | 0.5 | 0.7 | dnr after sadm | 15 | 63 | 6.299805 | 68 | 26 | 36.39844 | 210 | 2.199707 | 5.099609 | 1 | 142 | 7.449219 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
4,187 | 81.07599 | 1 | male | 0 | 27 | 30 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 7 | under $11k | 9 | 40,158.719 | 27,819.7812 | null | 14.5 | white | 32.695313 | 41 | 0.429993 | 0.310974 | 6 | 0 | 0 | no | null | null | dnr after sadm | 9 | 47 | 12.5 | 42 | 25 | 36.29688 | 190 | 2.899902 | null | 1.199951 | 139 | 7.469727 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
4,188 | 83.90997 | 1 | female | 0 | 9 | 307 | COPD | COPD/CHF/Cirrhosis | 1 | 14 | $11-$25k | 0 | 7,561.797 | 5,520.7109 | null | 14 | white | 19.398438 | 22 | 0.766968 | 0.628906 | 1 | 0 | 0 | no | null | null | no dnr | 9 | 108 | 7.699219 | 120 | 20 | 36.89844 | 390 | null | 0.399963 | 0.699951 | 143 | 7.219727 | null | null | null | 1 | 7 | adl>=4 (>=5 if sur) | 7 |
4,189 | 88.58899 | 0 | female | 0 | 17 | 1,359 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | null | null | null | 14.666664 | white | 29.796875 | 45 | 0.380981 | 0.185974 | 10 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 3 | 69 | 13 | 64 | 35 | 34.79688 | 110.20312 | null | null | 1.199951 | 139 | 7.469727 | null | null | null | null | 0 | SIP>=30 | 0 |
4,190 | 68.73395 | 1 | male | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 7 | $11-$25k | 26 | 34,104.062 | 21,455.3281 | null | 47 | white | 40.195313 | 72 | 0.28894 | 0.178986 | 1 | 1 | 0 | no | 0.05 | 0.000125 | no dnr | 6 | 46 | 10.099609 | 160 | 40 | 39.09375 | 112 | 2.699707 | 0.099991 | 1.799805 | 143 | 7.589844 | null | null | null | null | null | <2 mo. follow-up | 2.38916 |
4,191 | 39.01398 | 1 | female | 0 | 10 | 552 | Colon Cancer | Cancer | 1 | 16 | $25-$50k | 0 | 15,749.195 | 9,910.6797 | null | 13.5 | hispanic | 12.898438 | 5 | 0.896973 | 0.763916 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 10 | 85 | 9.398438 | 76 | 20 | 36.29688 | null | 3.799805 | 0.599976 | 0.599976 | 142 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
4,192 | 72.62695 | 0 | male | 0 | 48 | 1,358 | Coma | Coma | 0 | 6 | under $11k | 61 | 114,186.188 | 77,824.25 | null | 24 | white | 21.296875 | 17 | 0.317993 | 0.246979 | 7 | 0 | 0 | no | 0.6 | 0.55 | no dnr | 48 | 109 | 17.199219 | 56 | 28 | 37.5 | 316.625 | null | null | 0.799927 | 131 | 7.429688 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
4,193 | 65.32794 | 1 | male | 0 | 5 | 307 | Lung Cancer | Cancer | 1 | 17 | >$50k | 0 | 6,116.098 | 3,664.3906 | null | 10 | white | 14.699219 | 15 | 0.750977 | 0.490967 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 100 | 10 | 64 | 20 | 36.69531 | null | null | 0.5 | 1 | 139 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,194 | 33.16898 | 0 | male | 0 | 24 | 1,355 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 49,249.938 | 31,747.3594 | null | 18.333328 | white | 34.296875 | 50 | 0.695923 | 0.530884 | 2 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 24 | 44 | 5.399414 | 120 | 27 | 36.5 | 480.9375 | 2.5 | 1.199951 | 2.199707 | 141 | 7.449219 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
4,195 | 72.70398 | 1 | male | 0 | 21 | 207 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 4 | null | 0 | 49,507.219 | 33,661.8125 | null | 26.333328 | white | 29 | 37 | 0.621948 | 0.517944 | 1 | 0 | 0 | yes | 0.3 | 0.15 | dnr after sadm | 10 | 132 | 21.796875 | 126 | 23 | 38.69531 | 110 | 2.299805 | 0.299988 | 0.699951 | 133 | 7.429688 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
4,196 | 63.27399 | 1 | female | 0 | 5 | 201 | Lung Cancer | Cancer | 1 | 10 | $25-$50k | 0 | 5,416.098 | 3,314.0606 | null | 8 | white | 16.199219 | 15 | 0.727905 | 0.454956 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 96 | 11.898438 | 76 | 28 | 37.39844 | null | null | 0.299988 | 0.699951 | 141 | null | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
4,197 | 23.85199 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 100 | 67,589.312 | 43,827.4062 | null | 39 | black | 36.398438 | 68 | 0.268982 | 0.161987 | 4 | 0 | 0 | no | 0.2 | 0.1 | no dnr | 7 | 127 | 8.898438 | 160 | 36 | 35.39844 | 404 | null | 13.599609 | 1.399902 | 161 | 7.509766 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
4,198 | 65.79297 | 1 | male | 0 | 4 | 31 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 5,295.699 | 3,165.8652 | null | 16 | white | 16.796875 | 22 | 0.710938 | 0.429993 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 4 | 77 | 21.199219 | 84 | 24 | 37.59375 | null | null | 0.699951 | 1.199951 | 132 | null | null | null | null | null | null | <2 mo. follow-up | 2.015625 |
4,199 | 76.18097 | 0 | female | 0 | 6 | 1,350 | Colon Cancer | Cancer | 1 | 13 | under $11k | 0 | 5,235.797 | 3,665.3242 | null | 10 | white | 16.5 | 15 | 0.803955 | 0.581909 | 1 | 0 | 0 | metastatic | null | null | no dnr | 6 | 100 | 3.099609 | 68 | 20 | 36.79688 | null | 3.299805 | 0.299988 | 0.799927 | 143 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,200 | 53.13898 | 1 | male | 0 | 6 | 376 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 3,427.949 | 2,561.9609 | null | 9 | white | 20.199219 | 13 | 0.671997 | 0.373962 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 6 | 110 | 9.898438 | 100 | 20 | 36.79688 | null | null | null | 0.399963 | 136 | null | null | null | null | 0 | 5 | no(M2 and SIP pres) | 5 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.